catechin has been researched along with Coronary Restenosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Y; Li, X; Liu, C; Shang, T; Wang, J; Wang, K; Zhang, L; Zhao, Y; Zhou, L | 1 |
| Fay, WP; Katti, K; Katti, KV; Khoobchandani, M; Maxwell, A | 1 |
| Ahn, HY; Cho, MC; Hwang, KK; Kim, CH; Kim, DW; Kim, YG; Kwon, JS; Park, JB; Park, YS; Piao, H; Sachinidis, A; Youn, TJ; Yun, YP | 1 |
3 other study(ies) available for catechin and Coronary Restenosis
| Article | Year |
|---|---|
Application of a Reactive Oxygen Species-Responsive Drug-Eluting Coating for Surface Modification of Vascular Stents.
Topics: Animals; Catechin; Cell Movement; Cell Proliferation; Cells, Cultured; Coated Materials, Biocompatible; Coronary Restenosis; Cystamine; Drug Liberation; Drug-Eluting Stents; Endothelial Cells; Macrophages; Male; Myocytes, Smooth Muscle; Neovascularization, Physiologic; Oxidation-Reduction; Quinolines; Rabbits; Rats, Sprague-Dawley; Reactive Oxygen Species; Stainless Steel | 2021 |
Laminin Receptor-Avid Nanotherapeutic EGCg-AuNPs as a Potential Alternative Therapeutic Approach to Prevent Restenosis.
Topics: Anti-Inflammatory Agents; Antioxidants; Catechin; Cell Line; Cell Movement; Cell Proliferation; Coronary Restenosis; Drug Carriers; Endothelial Cells; Gold; Human Umbilical Vein Endothelial Cells; Humans; Metal Nanoparticles; Myocytes, Smooth Muscle; Receptors, Laminin; Ribosomal Proteins | 2016 |
Local delivery of green tea catechins inhibits neointimal formation in the rat carotid artery injury model.
Topics: Angiography; Angioplasty; Animals; Carotid Arteries; Carotid Artery Injuries; Catechin; Cell Proliferation; Coronary Restenosis; Enzymes; Male; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Rats; Rats, Inbred F344; Recombinant Proteins; Tea; Tunica Intima | 2004 |